chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Inability to sleep; Body aches; Skin uncomfortable to touch,; 4 days with a fever; the first two with a fever between 103-104,; Injection site red and swollen to the circumference of a golf ball.; Injection site red and swollen to the circumference of a golf ball.; Severe body chills; On the 4th day after, my left ear(the same side I got the injection on) feels clogged up; This is a spontaneous report from a contactable consumer (patient). A 24-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 01Jul2021 11:30 (at the age of 24-years-old) as dose number unknown, single for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient past Medical history included irritable bowel syndrome (IBS-C) from an unknown date and unknown if ongoing, vertigo from an unknown date and unknown if ongoing, chronic migraine from an unknown date and unknown if ongoing, known allergies for latex from an unknown date and unknown if ongoing. Concomitant medication(s) included cyanocobalamin (B12) supplement taken for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 01Jul2021, the patient experienced injection site red and swollen to the circumference of a golf ball, 4 days with a fever; the first two with a fever between 103-104, inability to sleep, severe body chills, body aches, skin uncomfortable to touch, on the 4th day after, on unspecified date in Jul2021, her left ear (the same side she got the injection on) feels clogged up like there's water in it. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included Body temperature: 103-104 on 01Jul2021. The patient was treated with pain relievers for fever and unspecified treatment for rest all other. The outcome for events was not recovered. Device date was 04Jul2021. Information on the lot/batch number has been requested.
Fever, body aches, very sore arm, fatigue  Lasted about 30 hours.
Pt received MENACTRA and not long after pt developed a rash at injection site that spread to chest arm and leg, pt was taken to ER required steroids and spread.
I was having my menstrual cycle when I got my second vaccine. Approximately 24 hours after receiving my second COVID vaccine, my bleeding became very heavy and I passed a large amount of clots. This lasted approximately 8 hours then stopped. Previous periods have been light, as I had a tubal ligation and ablation several years ago. After this incident, I did not have a period for 2 months. My cycle has since resumed.
sore arm; chills; headache; dose was given on the 34th day after the vial was thawed; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given on the 34th day after the vial was thawed), VACCINATION SITE PAIN (sore arm), CHILLS (chills) and HEADACHE (headache) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jul-2021 at 1:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021 at 1:30 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given on the 34th day after the vial was thawed). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm), CHILLS (chills) and HEADACHE (headache). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (MORTIN) at an unspecified dose and frequency. On 13-Jul-2021, EXPIRED PRODUCT ADMINISTERED (dose was given on the 34th day after the vial was thawed) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: no (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Aug-2021: Follow up received included patient demographics, contact information updated and updated stop date of the event dose was given on the 34th day after the vial was thawed, Lab data updated, 2nd dose time updated.
Fatigue/ exhaustion; Brain fog; Memory issues; Attentions issued (she cannot concentrate enough to watch a video or processing a lot of video or a lot of light); Severe headaches; Migraine; Light sensitivity; Difficulty sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Concussion", start date: 2019 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 03Mar2021, outcome "unknown", described as "Fatigue/ exhaustion"; FEELING ABNORMAL (non-serious) with onset 03Mar2021, outcome "unknown", described as "Brain fog"; MEMORY IMPAIRMENT (non-serious) with onset 03Mar2021, outcome "unknown", described as "Memory issues"; DISTURBANCE IN ATTENTION (non-serious) with onset 03Mar2021, outcome "unknown", described as "Attentions issued (she cannot concentrate enough to watch a video or processing a lot of video or a lot of light)"; HEADACHE (non-serious) with onset 03Mar2021, outcome "unknown", described as "Severe headaches"; MIGRAINE (non-serious) with onset 03Mar2021, outcome "unknown", described as "Migraine"; PHOTOPHOBIA (non-serious) with onset 03Mar2021, outcome "unknown", described as "Light sensitivity"; INSOMNIA (non-serious) with onset 03Mar2021, outcome "unknown", described as "Difficulty sleeping". The events "fatigue/ exhaustion", "brain fog", "memory issues", "attentions issued (she cannot concentrate enough to watch a video or processing a lot of video or a lot of light)", "severe headaches", "migraine", "light sensitivity" and "difficulty sleeping" were evaluated at the physician office visit and emergency room visit.  Additional Information: The patient reported the events she was experiencing was almost the same symptoms as when she had a concussion on 2019. Since the first week after the administration of the vaccine, the patient had spoken with her Physician for more information and management. The week before the day of report, the patient had to be admitted into the Emergency Room for the management of the symptoms reported. It was further reported that she has now an appointment with her Neurologist.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
C/O dizziness and vomiting (4-5X) approx 1-2 hours after vaccination. After going to have lunch. Had slt headache and arm and flank soreness. Seen at ER approx 6 hours after vaccine. Given Benadryl and Motrin.
This a continuation from 1st dose on 1/14 exp heavy bleeding. I had a urgent visit on 1/15 since I haven't had any bleeding.(estimated  date of delivery 9/7/2021)
Approximately 3 months after vaccination contracted breakthrough case of COVID-19 aboard cruise ship. Symptoms included fatigue, sore throat. achy, tired, congestion, cough, and ear ache. Developed two secondary infections, symptoms began to improve after secondary infections were addressed with antibiotics. Symptoms mostly resolved after 7 days but still having persistent dry cough and minor fatigue.
After a few days,  a rash appeared on both legs from foot to buttock.  Very itchy, worse at night.  It lasted about 10 days.
Pain in bilateral lower extremities that started after 1st dose of COVID vaccine. US completed on 4/16/21 showed superficial blood clot in right leg. Treatment included: warm compresses, taking ibuprofen 600 mg with food three times daily, and elevation of your right lower extremity. Outcome: unknown.
Evaluation resulted in a diagnosis of Pancreatic Cancer. Removal of cancerous lesion on 9/16 and started on chemotherapy.
Intense burning along left side of chest and upper inner left arm started 2 to 3 hours after vaccine. Helped a little the next day by ibuprofen but still painful just lessened it a little. Part of the pain occurred where I had been feeling an ache at left upper chest since March 2022 in area where node removed with left mastectomy. Previously pain very mild and very licalixed to upper left chest near axilla now intense burning pain in much larger area unrelenting kept me from sleeping.
Shortness of breath Dx Chest Pain NSTEMI Increased tropinon Pulmonary Embolism Meds ASA Heparin lorazapam
Same day post vax, the pt was unresponsive; staring (not unconscious). Pt seemed unable to speak. When she was able to speak, she complained of heaviness of arm and legs, unable to move legs. Stated she felt a little tightness in her chest and nausea. She was taken to ER and then discharged home. The next day she was absent from school and states she felt weak and tired.
Mother called on 8/16/00, stating child had a knot and swelling in her right arm from deltoid to elbow and wanting to know IZ given to child on 8/15/00. Taking child to ER. MD advised mom that child had a reaction to one of the shots given. Advised to give the child Benadryl. RN checked on child on 8/17/00 and redness and swelling was still present. Continuing to give Benadryl per MD's orders.
11/22 pt's (R) delt developed red edematous area size of 25 cent. Pt was given 5ml MOTRIN -- area hot to touch, 730 pm site of injection (R) deltoid area size of baseball according to mom. Mother applied cool compress and gave BENADRYL/MOTRIN. Pt afebrile after meds edema and redness decreased 11/23 - white line from site to shoulder noted with reddened circle at site - 9:30 AM - P.M. called.
Dyspnea c/o.  Pt is on 2 liters at home.  COVID positive recently.  Hypoxia concerns with exertion.   Pt is currently on 6 liters via NC, but plan to place on Bipap.                                                                                   patient was a transfer to our facility. one dose of the vaccine was administered on 2/1/2021 but no record of lot number
Within one week of my second dose, I developed jaw pain.  My jaw would not close properly.  This pain persists until this day.  The pain level remained constant for months.  I visited with the dentist and was referred to a physical therapist.  I attend physical therapy once a week but the pain is slowly getting better with this therapy.  Also, I want to mention that after dose 2 I had muscle aches, nausea, headache, These symptoms began the day after dose 2 and lasted about a week and a half.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated subcutaneously with a 0.5 ml dose of ZOSTAVAX (lot # not reported) on 23-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that the patient went back and presented with an "injection site reaction with tenderness and warmth at injection site and swelling that went to her elbow". No treatment information was reported. The outcome of tenderness and warmth at injection site and swelling that went to her elbow was reported as not recovered. The relatedness for the reported events was not provided for ZOSTAVAX. Additional information is not expected.
menstrual cycle changed for 4 months; rashes all over my face; This spontaneous case was reported by a patient and describes the occurrence of MENSTRUAL DISORDER (menstrual cycle changed for 4 months) and RASH (rashes all over my face) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (menstrual cycle changed for 4 months) and RASH (rashes all over my face). At the time of the report, MENSTRUAL DISORDER (menstrual cycle changed for 4 months) and RASH (rashes all over my face) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Short of breath & wheezing with general malaise within 24 hrs after receiving Tdap & TWINRIX on 11/10/11 cough started 11/13/11 (prone to pneumonia) persistent SOB & cough still today.
2 hours after the rash felt lethargic and complained of pruritus then 3-4 hours later developed diffuse non urticarial rash.
I21.19 ACUTE ST ELEVATION MI, INFEROLATERAL WALL 11/13/2022 HX OF ST ELEVATION MI; I95.9 HYPOTENSION 11/17/2022 HX OF ST ELEVATION MI; J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE; 11/13/2022 HX OF ST ELEVATION MI; R57.0 CARDIOGENIC SHOCK 11/13/2022 HX OF ST ELEVATION MI; I21.19 ACUTE ST ELEVATION MI, INFEROLATERAL WALL 11/13/2022; HX OF ST ELEVATION MI; ACUTE ST ELEVATION MI, INFEROLATERAL WALL; I95.9 HYPOTENSION 11/17/2022 HX OF ST ELEVATION MI; ACUTE ST ELEVATION MI, INFEROLATERAL WALL; J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/13/2022 HX OF ST ELEVATION MI; ACUTE ST ELEVATION MI, INFEROLATERAL WALL; R57.0 CARDIOGENIC SHOCK 11/13/2022 HX OF ST ELEVATION MI; ACUTE ST ELEVATION MI, INFEROLATERAL WALL; I21.19 ACUTE ST ELEVATION MI, INFEROLATERAL WALL 11/13/2022 HYPOTENSION; I95.9 HYPOTENSION 11/17/2022 HYPOTENSION; J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/13/2022 HYPOTENSION; R57.0 CARDIOGENIC SHOCK 11/13/2022 HYPOTENSION.
Pt within one minute of FLUARIX being administrated experience severe shortness of breath and was given one dose of Epipen 0.3 mg and responded well.
This spontaneous report was received from a back office lead and refers to a 29 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 31-MAR-2014, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (lot # and expiration date was not reported) 1 ml, intramuscularly (dose number was not provided). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Case number PHEH2015US008637, is an initial spontaneous report from a nurse received on 30 Apr 2015. This report refers to an 18-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient does not have any known allergies and had tolerated vaccines in the past. The patient was vaccinated with MENVEO (batch number: M14075) intramuscularly into the deltoid on 29 Apr 2015. On the same day after vaccination, the patient experienced swelling, warmth and hardness across the arm from the deltoid to elbow of the arm of MENVEO administration. The reporter insisted that the warmth, hardness and swelling was approximately three inches away from the injection site and does not incorporate the injection site. The patient did not receive any vaccine concomitantly. On 30 Apr 2015, the patient went to a clinic and was being treated for cellulitis in the arm. The final outcome of the events was unknown. Seriousness and causality was not reported. Seriousness of the event cellulitis in the arm was upgraded based on NVS-IME list.
Lethargy; This is a spontaneous report from a contactable consumer (patient) via a sales representative. The patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced lethargy on an unspecified date.  Event took place after use of product. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
On 2/27, pain in left neck, collar bone, shoulder and upper left arm. On 2/29, went back to work. On 3/10, had excruciating pain at collar bone and arm with numbness in left hand. Was out of work since 3/10. Taking Vicodin, 500mg, 2 every 4-6 hours. Have itching at injection site. Pharmacist, mother and I feel shot was given too high, near bone. Per follow-up, the pt still has numbness in left hand, twinges in upper forearm and above elbow. Pain still in shoulder. The annual follow-up states chronic numbness in left thumb, when damp or humid outside. Pain or discomfort in left upper shoulder at injection site. The pt also states that there should be mandatory vaccine lot number recordings because of what had happened to her.
Pain in neck and left shoulder and arm within 4 days of vaccination. Saw a doctor, and had several tests done including an MRI. The Neurologist confirmed Parsonage Turner syndrome. Several weeks later I had an EMG done, and the doctor again confirmed that diagnosis. I have limited ability to lift weight any weight over my head  with my left arm. I have muscle loss showing in my shoulder and back. I have not regained any of my previous strength prior to the vaccine.
Rash, pain at injection site.  Area is firm and feels hot and some numbness on skin over  Small Pox or BGC (?) Vaccine scar.
He took all of the Pfizer vaccines and boosters, all four, two boosters and Pfizer shots, and he thinks he caught COVID; He took all of the Pfizer vaccines and boosters, all four, two boosters and Pfizer shots, and he thinks he caught COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "He took all of the Pfizer vaccines and boosters, all four, two boosters and Pfizer shots, and he thinks he caught COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (01Sep2022) Positive, notes: he contracted COVID for a second time, and yesterday tested positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial and follow-up information has been received from a physician and a registered nurse concerning an 9 year old female, also reported as 11 year old, with no relevant medical history or allergies, who on 04-SEP-2008 was vaccinated with dose of GARDASIL intramuscularly in the right deltoid. Concomitant therapy included MENACTRA and ADACEL (UF452AA) intramuscularly in the left deltoid. On 04-SEP-2008 3-5 minutes after the vaccination, the patient passed out at the front desk. The patient was unconscious for a few seconds. Her vital signs were stable. The patient bruised her chin and cheek. The patient was sent home with an icepack with her mother. It was unknown if the patient sought any medical attention. On 04-SEP-2008, the patient recovered from the events. Additional information is not expected.
Patient states she received a flu shot yesterday during an office visit, and had a sore throat within an hour after receiving the shot, then 2 hours later started vomiting and continued for 90 minutes, no pain/swelling at injection site. Patient states both sore throat and vomiting have resolved and at the time of this phone call (11:04 am) she feels weak, chills, sweats, patient states no fever and she is recovering.
Cataract; Nerve Damage; Post Herpetic Neuralgia; Shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age.The pt's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the pt was vaccinated with zoster vaccine live(ZOSTAVAX)(dose, route of administration, anatomical location, lot#, expiration date were unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After injection, pt suffered a painful blistering rash, issues with her vision and nerve pain. As a result of her symptoms, pt presented to a medical provider and was diagnosed with Shingles, Post Herpetic Neuralgia, Cataract and Nerve Damage. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt's symptoms had resulted in physical limitations not present prior to using zoster vaccine live(ZOSTAVAX). Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the zoster vaccine live(ZOSTAVAX), pt sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live(ZOSTAVAX),pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.   Cataract, herpes zoster, post herpetic neuralgia and nerve injury were considered to be disability. Upon internal review, cataract was determined to be medically significant.
Patient under age 18 was vaccinated with Moderna, which is a vaccine error, on 3/22/2021 008B21A. Per data system, this was her second vaccine, with no record of a first vaccine. Troubleshooting: Scribe and vaccinator did not validate age;  screeners at the beginning of the process did not ask or turn away on a Moderna-only day. Second vaccine would have been given per standing orders. Unreported as error, found in data mining. Age restriction/confirmation rules were put into effect after the date of the first vaccine to prevent underage vaccines.